ARTICLE | Clinical News
Aezea cenersen sodium regulatory update
October 20, 2008 7:00 AM UTC
EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for Aezea cenersen to treat chronic lymphocytic leukemia (CLL). The antisense oligonucl...